Dénes Bánhegyi

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

José Valdez Madruga, Daniel Berger, Marilyn McMurchie et al. · The Lancet · 2007 · 330 citations

Treatment And Prevention, Antiviral Drug Development, Antiviral Therapy +5

Abnormal Antithrombin III (Antithrombin III ‘Budapest’) as a Cause of a Familial Thrombophilia

G. Sas, G Blaskó, Dénes Bánhegyi et al. · Thrombosis and Haemostasis · 1974 · 185 citations

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

Remko van Leeuwen, Christine Katlama, Robert L. Murphy et al. · AIDS · 2003 · 171 citations

Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing

Anne–Mieke Vandamme, Anders Sönnerborg, Mounir Ait‐Khaled et al. · Antiviral Therapy · 2004 · 144 citations · Full text

Pharmacotherapy, Resistance Testing, Clinical Use +17

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial

Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barrúz et al. · The Lancet HIV · 2021 · 102 citations

Epigenetic Age Acceleration, Sexual Health, Hiv/aids Counselling +12